SNIPR Biome has dosed the first patient in its Phase 1b trial of SNIPR001, a CRISPR-CAS-armed bacteriophage therapy that represents a new frontier in...
A new computational framework called CCLMoff uses deep learning and RNA language models to predict off-target effects in CRISPR-CAS9 genome editing...
Modalis Therapeutics has partnered with SOLVE FSHD to advance the development of an experimental epigenome-editing therapy for facioscapulohumeral...
Today, researchers in researchers in South Korea announced a method to selectively install N4-acetylcytidine (ac4C) modifications on specific RNA...
Researchers in Spain and Germany report using CRISPR-mediated exon removal to restore collagen production in cells from patients with recessive...
Researchers have developed a CRISPR-CAS base editing approach to treat trinucleotide repeat disorders by introducing protective interruptions into...
Scientists have developed a new adenine base editor (ABE) that matches the efficiency of the widely used ABE8e while offering significantly improved...
Scientists have developed a novel gene editing system that significantly enhances targeted gene integration without using viral vectors. The 'enGager'...
